07 Jul 2018
12:30 - 13:40
Level 6, Mandarin Grand Ballroom, Mandarin Orchard
Lunch
| 1230 – 1340 | Lunch |
|---|---|
| 1245 – 1315 | Lunch Symposium (Sponsored by DCH Auriga Singapore) |
| Evolution of Infliximab Biosimilar: CT-P13 | |
| Key Clinical Evidence of CT-P13: From Concept to Clinical Practice – 3.4 CD RCT (Switching Data for 54 weeks) – SC Trial |
|
| 1315 – 1340 | Lunch (continuation) and Viewing of Posters and Exhibitions |